These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25623769)

  • 1. [Clinical features and prognostic analysis of mantle cell lymphoma patients].
    Zhou P; Shi Y; He X; Zhou S; Liu P; Dong M; Qin Y; Yang J; Zhang C; Zhou L; Yang S; Gui L
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):928-32. PubMed ID: 25623769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical features, therapeutic effects and prognosis of mantle cell lymphoma].
    Zhang HX; Xu J; Liu T; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):231-5. PubMed ID: 21569704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 140 cases of mantle cell lymphoma].
    Hu MW; Lou YJ; Yang M; Wang HF; Wang L; Jin J
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):390-395. PubMed ID: 29860768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical analysis of the character and prognostic factors of 23 cases of mantle cell lymphoma].
    Liang R; Wang Z; Zhu MN; Hao CX; Zhang N; Wang JH; Zhang T; Yang L; Gu HT; Dong BX; Bai QX; Gao GX; Chen XQ
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):491-6. PubMed ID: 27431074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognostic analysis of mantle cell lymphoma].
    Bao WY; Wang Y; Hu XM; Li JM; Shen ZX; Zhao WL
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):814-8. PubMed ID: 23384900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and Prognosis of Chemotherapy Regimen Containing BTK Inhibitor in Treatment of Recurrent/Refractory Mantle Cell Lymphoma].
    Chen H; Liu XY; Chang Y; Chen ZQ; Li WQ; Zhang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):125-131. PubMed ID: 38387910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype.
    Bernard M; Gressin R; Lefrère F; Drénou B; Branger B; Caulet-Maugendre S; Tass P; Brousse N; Valensi F; Milpied N; Voilat L; Sadoun A; Ghandour C; Hunault M; Leloup R; Mannone L; Hermine O; Lamy T
    Leukemia; 2001 Nov; 15(11):1785-91. PubMed ID: 11681422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma.
    Liang X; Guo L; Hu X; Li S; Wen S
    Medicine (Baltimore); 2021 Apr; 100(13):e25194. PubMed ID: 33787601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
    Jo JC; Kim SJ; Lee HS; Eom HS; Lee SI; Park Y; Lee JO; Lee Y; Yhim HY; Yang DH; Byun JM; Kang HJ; Kim HJ; Shin HJ; Yoo KH; Suh C;
    Ann Hematol; 2020 Feb; 99(2):223-228. PubMed ID: 31853704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical Characteristics and Outcome of 66 Cases of Mantle Cell Lymphomas].
    Wu Y; Wang H; Liu XJ; Wang YY; Zhao WL; Li JM; Shen ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1036-1041. PubMed ID: 28823264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simplified MIPI-B prognostic stratification method can predict the outcome well-retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China.
    He JS; Chen X; Wei GQ; Sun J; Zheng WY; Shi JM; Wu WJ; Zhao Y; Zheng GF; Huang H; Cai Z
    Medicine (Baltimore); 2019 Jan; 98(1):e13741. PubMed ID: 30608386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and prognostic factors of elderly patients with mantle cell lymphoma].
    Hao XY; Yang P; Zhang W; Liu H; Sun XH; Xiao XB; Wang JW; Li ZL; Li LH; Wang SY; He J; Li XL; Jing HM
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jun; 44(6):495-500. PubMed ID: 37550206
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphoma.
    El-Galaly TC; Villa D; Alzahrani M; Hansen JW; Sehn LH; Wilson D; de Nully Brown P; Loft A; Iyer V; Johnsen HE; Savage KJ; Connors JM; Hutchings M
    Am J Hematol; 2015 Nov; 90(11):1041-6. PubMed ID: 26260224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mantle cell lymphoma: clinicopathologic features and prognostic factors of 102 cases occurring in Chinese patients].
    Ji H; Li GD; Li FY; Bai YQ; Chen Y; Yang MZ; Wang LJ; Tang Y; Zhang P; Xia T; Li C; Feng J; Zou ZK; Yixi JC
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):730-5. PubMed ID: 18307875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mantle cell lymphoma in Thai patients.
    Intragumtornchai T; Rojnuckarin P; Sutcharitchan P; Wannakrairot P
    J Med Assoc Thai; 2004 Sep; 87(9):1071-5. PubMed ID: 15516008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Characteristics and Prognosis of 34 Patients with Mantle Cell Lymphoma: A Retrospective Analysis].
    Chen XP; Zhao Y; Wang QS; Lv N; Li YH; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1601-6. PubMed ID: 26708879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
    Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.